Methylation-Based Therapies for Colorectal Cancer
Open accessThe DOI matches its Crossref record; 236 of the 241 references it cites were found in a registry or an index.
Abstract
Colorectal carcinogenesis (CRC) is caused by the gradual long-term accumulation of both genetic and epigenetic changes. Recently, epigenetic alterations have been included in the classification of the CRC molecular subtype, and this points out their prognostic impact. As epigenetic modifications are reversible, they may represent relevant therapeutic targets. DNA methylation, catalyzed by DNA methyltransferases (DNMTs), regulates gene expression. For many years, the deregulation of DNA methylation has been considered to play a substantial part in CRC etiology and evolution. Despite considerable advances in CRC treatment, patient therapy response persists as limited, and their profit from systemic therapies are often hampered by the introduction of chemoresistance. In addition, inter-individual changes in therapy response in CRC patients can arise from their specific (epi)genetic compositions. In this review article, we summarize the options of CRC treatment based on DNA methylation status for their predictive value. This review also includes the therapy outcomes based on the patient’s methylation status in CRC patients. In addition, the current challenge of research is to develop therapeutic inhibitors of DNMT. Based on the essential role of DNA methylation in CRC development, the application of DNMT inhibitors was recently proposed for the treatment of CRC patients, especially in patients with DNA hypermethylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, excessive demethylation by DNMT inhibitors can also disrupt normal gene expression patterns and cause toxicity [158].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [158]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedPD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 1×
“and are predominantly associated with transcription start sites and promoters [7].”
BackgroundThe consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440 · cited 1×
“The process of transcriptional repression also requires the so-called “reader” molecules, known as methyl-binding proteins (MBPs) and their corepressors, such as histone deacetylases (HDAC1 and HDAC2), Sin3A, and Mi-2 [69].”
BackgroundESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
DNA methylation: roles in mammalian development
Smith, Z. D., & Meissner, A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3354 · Cited by 3,045 · cited 1×
“DNMTs can be categorized according to their function into three groups: most abundant DNMT1, de novo DNMTs (DNMT3A and DNMT3B), and DNMT2 (with methylation activity for tRNA) [64,65].”
BackgroundOverman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637 · cited 1×
“However, many methylation alterations are cancer-specific and appear early in the cancer genome [85], long before the malignant transition, and enlarge with progression [86].”
BackgroundMicrosatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204 · cited 1×
“Moreover, polycomb (PcG) proteins can directly bind to DNMTs and thus regulate their activity [80].”
BackgroundIrizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177 · cited 2×
“However, tissue-specific methylation changes exist in “shores” and “shelves” surrounding them [60].”
BackgroundWeisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743 · cited 1×
“However, most of the genes have at least two TSSs, which likely to represent alternative promoters, and their methylation hampers the interpretation of experiments studying the expression linked to methylation [50,51].”
BackgroundMarisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001453 · Cited by 1,507
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02549.x · Cited by 1,384
Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain
Guo, J. U., Su, Y., Zhong, C., Ming, G.-L., & Song, H. (2011) · Cell · doi:10.1016/j.cell.2011.03.022 · Cited by 1,360 · cited 5×
“Methylated CGIs at transcriptional start sites (TSSs) are not able to establish transcription after assembling the DNA into nucleosomes [47–49].”
BackgroundInfluentialSCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191 · cited 1×
“First, aging has been shown to correlate with aberrant DNA hypermethylation [11].”
BackgroundMethylation of tRNA Asp by the DNA Methyltransferase Homolog Dnmt2
Goll, M. G., Kirpekar, F., Maggert, K. A., Yoder, J. A., Hsieh, C.-L., Zhang, X., Golic, K. G., Jacobsen, S. E., & Bestor, T. H. (2006) · Science · doi:10.1126/science.1120976 · Cited by 1,190
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Dynamic changes in the human methylome during differentiation
Laurent, L., Wong, E., Li, G., Huynh, T., Tsirigos, A., Ong, C. T., Low, H. M., Kin Sung, K. W., Rigoutsos, I., Loring, J., et al. (2010) · Genome Research · doi:10.1101/gr.101907.109 · Cited by 1,041 · cited 1×
“Exons have been shown to be more methylated than introns, and transitions in the level of methylation appear at the boundaries of exons and introns, which may indicate the importance of methylation in the regulation of splicing [41,42].”
BackgroundAmount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
Ehrlich, M., Gama-Sosa, M. A., Huang, L.-H., Midgett, R. M., Kuo, K. C., McCune, R. A., & Gehrke, C. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.8.2709 · Cited by 1,040 · cited 1×
“Although the brain contains the highest levels of methylated DNA, it is estimated that 5-mC counts for less than 1% of nucleic acids [6].”
BackgroundRole of the Serrated Pathway in Colorectal Cancer Pathogenesis
Leggett, B., & Whitehall, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.066 · Cited by 977
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
The CpG dinucleotide and human genetic disease
Cooper, D. N., & Youssoufian, H. (1988) · Human Genetics · doi:10.1007/bf00278187 · Cited by 931 · cited 1×
“Methylation of the CpG sites within exons is the main purpose of C→T transition mutation origin and is responsible for about 30% of all disease-causing mutations in the germline [39,40].”
BackgroundDNA methylation and healthy human aging
Jones, M. J., Goodman, S. J., & Kobor, M. S. (2015) · Aging Cell · doi:10.1111/acel.12349 · Cited by 928
Chromatin Compaction by a Polycomb Group Protein Complex
Francis, N. J., Kingston, R. E., & Woodcock, C. L. (2004) · Science · doi:10.1126/science.1100576 · Cited by 840 · cited 1×
“The mechanism of alternative gene silencing by Polycomb complex is through the trimethylation of histone H3, chromatin compaction, and regulation of H2A by monoubiquitylation [58,59].”
BackgroundArnold, D., Lueza, B., Douillard, J.-Y., Peeters, M., Lenz, H.-J., Venook, A., Heinemann, V., Van Cutsem, E., Pignon, J.-P., Tabernero, J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx175 · Cited by 838
Newlands, E. S., Stevens, M. F. G., Wedge, S. R., Wheelhouse, R. T., & Brock, C. (1997) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(97)90019-0 · Cited by 817
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
De Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3174 · Cited by 771
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Gascard, P., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 732
Genetic prognostic and predictive markers in colorectal cancer
Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I., & Kerr, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2645 · Cited by 705
Relationship between nucleosome positioning and DNA methylation
Chodavarapu, R. K., Feng, S., Bernatavichute, Y. V., Chen, P.-Y., Stroud, H., Yu, Y., Hetzel, J. A., Kuo, F., Kim, J., Cokus, S. J., et al. (2010) · Nature · doi:10.1038/nature09147 · Cited by 696 · cited 1×
“The nucleosome position data throughout the genome suggest that exons also evince a higher level of nucleosome occupancy in contrast to introns [43], and DNA methylation is higher in DNA comprising nucleosome than in flanking DNA [44].”
BackgroundAccelerated age-related CpG island methylation in ulcerative colitis.
Issa, J. J., Ahuja, N., Toyota, M., Bronner, M. P., & Brentnall, T. A. (2001) · PubMed · Cited by 690
Epigenetics and aging: the targets and the marks
Fraga, M. F., & Esteller, M. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.05.008 · Cited by 690 · cited 1×
“However, this number alters between diverse tissues and pathological status and is lower with increased age [8].”
BackgroundCancer associated fibroblasts (CAFs) in tumor microenvironment
Xing, F. (2010) · Frontiers in Bioscience · doi:10.2741/3613 · Cited by 682 · cited 1×
“They differ phenotypically and functionally from normal fibroblasts (NFs) and provide cancer cells with nutrition and energy and stimulate the proliferation, invasion, and metastasis of cells [94,95].”
BackgroundJüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665 · cited 1×
“As stated before, many CGIs are situated in promoters, but CGIs can be located within the gene body and in desserts [37].”
BackgroundFiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., & De Maria, R. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0994-2 · Cited by 647
Aging effects on DNA methylation modules in human brain and blood tissue
Horvath, S., Zhang, Y., Langfelder, P., Kahn, R. S., Boks, M. P., van Eijk, K., van den Berg, L. H., & Ophoff, R. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-r97 · Cited by 645
5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes
Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A. (1990) · Science · doi:10.1126/science.1697983 · Cited by 640 · cited 1×
“Methylation of the CpG sites within exons is the main purpose of C→T transition mutation origin and is responsible for about 30% of all disease-causing mutations in the germline [39,40].”
BackgroundChromatin organization marks exon-intron structure
Schwartz, S., Meshorer, E., & Ast, G. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1659 · Cited by 638 · cited 1×
“The nucleosome position data throughout the genome suggest that exons also evince a higher level of nucleosome occupancy in contrast to introns [43], and DNA methylation is higher in DNA comprising nucleosome than in flanking DNA [44].”
BackgroundDNA methylation: past, present and future directions
Robertson, K. D., & A.Jones, P. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.461 · Cited by 607
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Samowitz, W. S., Albertsen, H., Herrick, J., Levin, T. R., Sweeney, C., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.020 · Cited by 577
Yoshino, T., Arnold, D., Taniguchi, H., Pentheroudakis, G., Yamazaki, K., Xu, R.-H., Kim, T. W., Ismail, F., Tan, I. B., Yeh, K.-H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx738 · Cited by 573
Maunakea, A. K., Chepelev, I., Cui, K., & Zhao, K. (2013) · Cell Research · doi:10.1038/cr.2013.110 · Cited by 552 · cited 1×
“Exons have been shown to be more methylated than introns, and transitions in the level of methylation appear at the boundaries of exons and introns, which may indicate the importance of methylation in the regulation of splicing [41,42].”
BackgroundSinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
Jung, M., & Pfeifer, G. P. (2015) · BMC Biology · doi:10.1186/s12915-015-0118-4 · Cited by 535 · cited 1×
“While global hypomethylation is characteristic during aging, among age-dependent hypermethylated genes, many tumor suppressor genes have been reported (reviewed in [22,26].”
BackgroundAberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 530
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522
Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0307 · Cited by 507
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
Stunnenberg, H. G., Abrignani, S., Adams, D., de Almeida, M., Altucci, L., Amin, V., Amit, I., Antonarakis, S. E., Aparicio, S., Arima, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.007 · Cited by 495
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095992 · Cited by 493
FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension
Kaminskas, E., Farrell, A. T., Wang, Y.-C., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-176 · Cited by 490
DNA methylation and DNA methyltransferases
Edwards, J. R., Yarychkivska, O., Boulard, M., & Bestor, T. H. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0130-8 · Cited by 484 · cited 1×
“DNMT1 modifications are site-specific and enzyme-dependent [74,75].”
The role of DNA mismatch repair in drug resistance
Nebel, S. (1998) · ETH Zürich Research Collection · doi:10.3929/ethz-a-001915508 · Cited by 461
Molecular Classification and Correlates in Colorectal Cancer
Ogino, S., & Goel, A. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070082 · Cited by 460
Ishii, G., Ochiai, A., & Neri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.007 · Cited by 434
Li, H., Chiappinelli, K. B., Guzzetta, A. A., Easwaran, H., Yen, R.-W. C., Vatapalli, R., Topper, M. J., Luo, J., Connolly, R. M., Azad, N. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1782 · Cited by 430
Niwa, T., Tsukamoto, T., Toyoda, T., Mori, A., Tanaka, H., Maekita, T., Ichinose, M., Tatematsu, M., & Ushijima, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2755 · Cited by 417
The role of DNA mismatch repair in drug resistance.
Fink, D. A., Aebi, S. P., & Howell, S. B. (1998) · PubMed · Cited by 410
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
Budinska, E., Popovici, V., Tejpar, S., D'Ario, G., Lapique, N., Sikora, K. O., Di Narzo, A. F., Yan, P., Hodgson, J. G., Weinrich, S., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4212 · Cited by 409
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundMammalian DNA Methyltransferases: A Structural Perspective
Cheng, X., & Blumenthal, R. M. (2008) · Structure · doi:10.1016/j.str.2008.01.004 · Cited by 394 · cited 1×
“the attachment of a methyl group to a CpG dinucleotide on DNA strands during replication [66].”
BackgroundThe Role of DNA Methylation in Aging, Rejuvenation, and Age-Related Disease
Johnson, A. A., Akman, K., Calimport, S. R. G., Wuttke, D., Stolzing, A., & de Magalhães, J. P. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1324 · Cited by 389 · cited 1×
“While global hypomethylation is characteristic during aging, among age-dependent hypermethylated genes, many tumor suppressor genes have been reported (reviewed in [22,26].”
BackgroundDNA methyltransferases and their roles in tumorigenesis
Zhang, W., & Xu, J. (2017) · Biomarker Research · doi:10.1186/s40364-017-0081-z · Cited by 382 · cited 1×
“DNMT3A and DNMT3B are essential for de novo methylation of the genome, to keep a cell’s specific methylation profile, and also for methylation of newly integrated retroviral sequences [67,68].”
BackgroundGal-Yam, E. N., Egger, G., Iniguez, L., Holster, H., Einarsson, S., Zhang, X., Lin, J. C., Liang, G., Jones, P. A., & Tanay, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806437105 · Cited by 380
DNA methylation directs a time-dependent repression of transcription initiation
Kass, S. U., Landsberger, N., & Wolffe, A. P. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70086-1 · Cited by 370
Hawkins, N., Norrie, M., Cheong, K., Mokany, E., Ku, S., Meagher, A., O'Connor, T., & Ward, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32997 · Cited by 366
The role of DNA methylation in setting up chromatin structure during development
Hashimshony, T., Zhang, J., Keshet, I., Bustin, M., & Cedar, H. (2003) · Nature Genetics · doi:10.1038/ng1158 · Cited by 359
de Sousa E Melo, F., Colak, S., Buikhuisen, J., Koster, J., Cameron, K., de Jong, J. H., Tuynman, J. B., Prasetyanti, P. R., Fessler, E., van den Bergh, S. P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.008 · Cited by 332
Complex controls: the role of alternative promoters in mammalian genomes
Landry, J.-R., Mager, D. L., & Wilhelm, B. T. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.014 · Cited by 331 · cited 1×
“However, most of the genes have at least two TSSs, which likely to represent alternative promoters, and their methylation hampers the interpretation of experiments studying the expression linked to methylation [50,51].”
BackgroundTargeting DNA methylation for epigenetic therapy
Yang, X., Lay, F., Han, H., & Jones, P. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.001 · Cited by 326
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Chan, T. L., Yuen, S. T., Kong, C. K., Chan, Y. W., Chan, A. S., Ng, W. F., Tsui, W. Y., Lo, M. W., Tam, W. Y., Li, V. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1866 · Cited by 324 · cited 1×
“[88] analyzed germline hypermethylation of the MSH2 gene in a three-generation family with hereditary nonpolyposis colorectal cancer (HNPCC) without evidence of DNA mismatch repair gene mutations.”
BackgroundThe pathobiology of the septin gene family
Hall, P. A., & Russell, S. H. (2004) · The Journal of Pathology · doi:10.1002/path.1654 · Cited by 323
Nosho, K., Irahara, N., Shima, K., Kure, S., Kirkner, G. J., Schernhammer, E. S., Hazra, A., Hunter, D. J., Quackenbush, J., Spiegelman, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003698 · Cited by 311
Cigarette Smoking and Colorectal Cancer Risk by Molecularly Defined Subtypes
Limsui, D., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Weisenberger, D. J., Laird, P. W., Lynch, C. F., Anderson, K. E., French, A. J., Haile, R. W., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq201 · Cited by 305
Goel, A., Nagasaka, T., Arnold, C. N., Inoue, T., Hamilton, C., Niedzwiecki, D., Compton, C., Mayer, R. J., Goldberg, R., Bertagnolli, M. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.09.018 · Cited by 300
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
Takeshima, H., & Ushijima, T. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0079-0 · Cited by 300 · cited 1×
“DNA methylation seems to be caused by exposure to different natural stimulants and dietary factors [9,10].”
BackgroundConcise Drug Review: Azacitidine and Decitabine
Derissen, E. J. B., Beijnen, J. H., & Schellens, J. H. M. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0465 · Cited by 299
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
Induction of Epigenetic Alterations by Dietary and Other Environmental Factors
Mathers, J. C., Strathdee, G., & Relton, C. L. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380864-6.00001-8 · Cited by 292 · cited 1×
“DNA methylation seems to be caused by exposure to different natural stimulants and dietary factors [9,10].”
BackgroundIssa, J.-P. J., Gharibyan, V., Cortes, J., Jelinek, J., Morris, G., Verstovsek, S., Talpaz, M., Garcia-Manero, G., & Kantarjian, H. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.981 · Cited by 288
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Barault, L., Charon-Barra, C., Jooste, V., de la Vega, M. F., Martin, L., Roignot, P., Rat, P., Bouvier, A.-M., Laurent-Puig, P., Faivre, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1171 · Cited by 286
Nishida, N., Nagasaka, T., Nishimura, T., Ikai, I., Boland, R. C., & Goel, A. (2008) · Hepatology · doi:10.1002/hep.22110 · Cited by 286
Cohen, M. H., Johnson, J. R., & Pazdur, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0722 · Cited by 282
Ying, J., Li, H., Seng, T. J., Langford, C., Srivastava, G., Tsao, S. W., Putti, T., Murray, P., Chan, A. T. C., & Tao, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209154 · Cited by 281 · cited 1×
“DNA methylation of the promoter CGIs of tumor suppressor genes was suggested as an alternative mechanism in Knudson’s two-hit theory of tumor suppressor gene inactivation, and alongside the specific methylation profile, has been associated with the outcome of different cancer types [87].”
BackgroundLinhart, H. G., Lin, H., Yamada, Y., Moran, E., Steine, E. J., Gokhale, S., Lo, G., Cantu, E., Ehrich, M., He, T., et al. (2007) · Genes & Development · doi:10.1101/gad.1594007 · Cited by 274 · cited 1×
“DNMT3B1 but not DNMT3A1 methylated the same genes in tumors and in nonmalignant tissues, suggesting that de novo DNMTs can also trigger the methylation and silencing of specific genes in a nonmalignant cell [81].”
BackgroundSæterdal, I., Bjørheim, J., Lislerud, K., Gjertsen, M. K., Bukholm, I. K., Olsen, O. C., Nesland, J. M., Eriksen, J. A., Møller, M., Lindblom, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231326898 · Cited by 273
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., & Iacopetta, B. (2002) · Gut · doi:10.1136/gut.51.6.797 · Cited by 256
Lenz, H.-J., Ou, F.-S., Venook, A. P., Hochster, H. S., Niedzwiecki, D., Goldberg, R. M., Mayer, R. J., Bertagnolli, M. M., Blanke, C. D., Zemla, T., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02258 · Cited by 246
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Qin, T., Jelinek, J., Si, J., Shu, J., & Issa, J.-P. J. (2009) · Blood · doi:10.1182/blood-2008-02-140038 · Cited by 237
K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer
Esteller, M., González, S., Risques, R. A., Marcuello, E., Mangues, R., Germà, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.299 · Cited by 234
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
Linnebacher, M., Gebert, J., Rudy, W., Woerner, S., Yuan, Y. P., Bork, P., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1298 · Cited by 234
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Yagi, K., Akagi, K., Hayashi, H., Nagae, G., Tsuji, S., Isagawa, T., Midorikawa, Y., Nishimura, Y., Sakamoto, H., Seto, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2006 · Cited by 223
McGivern, A., Wynter, C. V. A., Whitehall, V. L. J., Kambara, T., Spring, K. J., Walsh, M. D., Barker, M. A., Arnold, S., Simms, L. A., Leggett, B. A., et al. (2004) · Familial Cancer · doi:10.1023/b:fame.0000039861.30651.c8 · Cited by 206
Jover, R., Nguyen, T., Pérez–Carbonell, L., Zapater, P., Payá, A., Alenda, C., Rojas, E., Cubiella, J., Balaguer, F., Morillas, J. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.035 · Cited by 205
Temozolomide in malignant gliomas: current use and future targets
Villano, J. L., Seery, T. E., & Bressler, L. R. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1050-5 · Cited by 202
Stintzing, S., Wirapati, P., Lenz, H.-J., Neureiter, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Al-Batran, S., Heintges, T., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz387 · Cited by 197
TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer
Ebert, M. P. A., Tänzer, M., Balluff, B., Burgermeister, E., Kretzschmar, A. K., Hughes, D. J., Tetzner, R., Lofton-Day, C., Rosenberg, R., Reinacher-Schick, A. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009473 · Cited by 189
Genetics supersedes epigenetics in colon cancer phenotype
Yamashita, K., Dai, T., Dai, Y., Yamamoto, F., & Perucho, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00190-9 · Cited by 188
Dietrich, N., Bracken, A. P., Trinh, E., Schjerling, C. K., Koseki, H., Rappsilber, J., Helin, K., & Hansen, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601632 · Cited by 187 · cited 1×
“Polycomb proteins repress gene expression by histone modification, especially during development and differentiation [56] and silence tumor suppressor genes [57].”
BackgroundThe Relationship between Hypomethylation and CpG Island Methylation in Colorectal Neoplasia
Bariol, C., Suter, C., Cheong, K., Ku, S.-L., Meagher, A., Hawkins, N., & Ward, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63932-6 · Cited by 183
Evrard, C., Tachon, G., Randrian, V., Karayan-Tapon, L., & Tougeron, D. (2019) · Cancers · doi:10.3390/cancers11101567 · Cited by 181
Trinh, A., Trumpi, K., De Sousa E Melo, F., Wang, X., de Jong, J. H., Fessler, E., Kuppen, P. J. K., Reimers, M. S., Swets, M., Koopman, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0680 · Cited by 180
Microsatellite instability: The mutator that mutates the other mutator
Perucho, M. (1996) · Nature Medicine · doi:10.1038/nm0696-630 · Cited by 177
Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers
Kanai, Y., Ushijima, S., Nakanishi, Y., Sakamoto, M., & Hirohashi, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00689-4 · Cited by 167 · cited 1×
“[84] noticed that mutational changes in the DNMT1 gene that lead to its inactivation in colon cancer cells resulted in changes in the specific DNA methylation profiles.”
BackgroundCorrelation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas
Spainhour, J. C., Lim, H. S., Yi, S. V., & Qiu, P. (2019) · Cancer Informatics · doi:10.1177/1176935119828776 · Cited by 165
Tougeron, D., Mouillet, G., Trouilloud, I., Lecomte, T., Coriat, R., Aparicio, T., Des Guetz, G., Lécaille, C., Artru, P., Sickersen, G., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv438 · Cited by 164
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
Plava, J., Cihova, M., Burikova, M., Matuskova, M., Kucerova, L., & Miklikova, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0960-z · Cited by 164 · cited 1×
“The carcinogenic process also involves the interactions between cancer cells and components of the surrounding microenvironment, consisting of the extracellular matrix, fibroblasts, endothelium, and vasculature-associated pericytes, as well as immune cells and occasional adipose cells [93].”
BackgroundOkita, A., Takahashi, S., Ouchi, K., Inoue, M., Watanabe, M., Endo, M., Honda, H., Yamada, Y., & Ishioka, C. (2018) · Oncotarget · doi:10.18632/oncotarget.24617 · Cited by 155
Foran, E., Garrity-Park, M. M., Mureau, C., Newell, J., Smyrk, T. C., Limburg, P. J., & Egan, L. J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0496 · Cited by 155 · cited 1×
“In colitis-associated CRC samples, the expression of DNMT1 was significantly higher than in sporadic CRC tumors, suggesting an increased level of DNA methylation in inflammatory tissues [35].”
BackgroundChuang, J. C., Warner, S. L., Vollmer, D., Vankayalapati, H., Redkar, S., Bearss, D. J., Qiu, X., Yoo, C. B., & Jones, P. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1048 · Cited by 155
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
Brunner-Weinzierl, M. C., & Rudd, C. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02737 · Cited by 153
Reed, M. C., Nijhout, H. F., Neuhouser, M. L., Gregory, J. F., Shane, B., James, S. J., Boynton, A., & Ulrich, C. M. (2006) · Journal of Nutrition · doi:10.1093/jn/136.10.2653 · Cited by 153 · cited 1×
“DNA hypomethylation has been observed during low folate supply and without vitamin B12 in the diet [19,20].”
BackgroundDifferential DNA hypermethylation and hypomethylation signatures in colorectal cancer
Frigola, J., Solé, X., Paz, M. F., Moreno, V., Esteller, M., Capellà, G., & Peinado, M. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi028 · Cited by 152
Ibrahim, A. E. K., Arends, M. J., Silva, A.-L., Wyllie, A. H., Greger, L., Ito, Y., Vowler, S. L., Huang, T. H.-M., Tavare, S., Murrell, A., et al. (2011) · Gut · doi:10.1136/gut.2010.223602 · Cited by 150 · cited 2×
“DNA hypermethylation of several CIMP-associated genes has been observed during the early CRC stages [82].”
BackgroundOka, D., Yamashita, S., Tomioka, T., Nakanishi, Y., Kato, H., Kaminishi, M., & Ushijima, T. (2009) · Cancer · doi:10.1002/cncr.24394 · Cited by 149 · cited 1×
“Cigarette smoking was noted to induce DNA hypermethylation in vitro, and it has been verified in vivo, where high levels of DNA methylation in nonmalignant tissues from the esophagus of smokers were observed [16].”
BackgroundAberrant DNA Methylation in Colorectal Cancer: What Should We Target?
Tse, J. W. T., Jenkins, L. J., Chionh, F. J. M., & Mariadason, J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.003 · Cited by 148
Adany, R., Heimer, R., Caterson, B., Sorrell, J. M., & Iozzo, R. V. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38605-3 · Cited by 147
Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
Yi, J. M., Dhir, M., Van Neste, L., Downing, S. R., Jeschke, J., Glöckner, S. C., de Freitas Calmon, M., Hooker, C. M., Funes, J. M., Boshoff, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2509 · Cited by 146
Mooi, J. K., Wirapati, P., Asher, R., Lee, C. K., Savas, P., Price, T. J., Townsend, A., Hardingham, J., Buchanan, D., Williams, D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy410 · Cited by 145
Johnson, K. C., Houseman, E. A., King, J. E., von Herrmann, K. M., Fadul, C. E., & Christensen, B. C. (2016) · Nature Communications · doi:10.1038/ncomms13177 · Cited by 143 · cited 1×
“Differential methylation is not limited to the CGIs but also applies to CpG regions, like at enhancers [62].”
BackgroundCOP9 Signalosome-directed c-Jun Activation/Stabilization Is Independent of JNK
Naumann, M., Bech-Otschir, D., Huang, X., Ferrell, K., & Dubiel, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35297 · Cited by 142
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Nosho, K., Shima, K., Irahara, N., Kure, S., Baba, Y., Kirkner, G. J., Chen, L., Gokhale, S., Hazra, A., Spiegelman, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2383 · Cited by 140 · cited 1×
“Interestingly, the overexpression of DNMT3B was associated with a CIMP-high in CRC [82,83].”
BackgroundEpithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome
Cheng, A. S. L., Culhane, A. C., Chan, M. W. Y., Venkataramu, C. R., Ehrich, M., Nasir, A., Rodriguez, B. A. T., Liu, J., Yan, P. S., Quackenbush, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5547 · Cited by 140 · cited 1×
“Another inducer of differences in DNA methylation has been ascribed to estrogen treatment in cultured mammary epithelial cells [17].”
BackgroundMolecular Mechanisms Underlying the Link between Diet and DNA Methylation
Kadayifci, F. Z., Zheng, S., & Pan, Y.-X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124055 · Cited by 138 · cited 1×
“DNA hypomethylation has been observed during low folate supply and without vitamin B12 in the diet [19,20].”
BackgroundDNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
Mahmood, N., & Rabbani, S. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00489 · Cited by 136 · cited 1×
“MBPs contain several proteins that are involved in chromatin remodeling and can be classified into three families based on the functional domains: MBPs with methyl binding domains (MBDs), MBPs that recognizes the methylated DNA according to the Zinc finger motifs, and MBPs with ability to bind methylated DNA using the…”
A Comparison of Colon and Rectal Somatic DNA Alterations
Slattery, M. L., Curtin, K., Wolff, R. K., Boucher, K. M., Sweeney, C., Edwards, S. L., Caan, B. J., & Samowitz, W. S. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a0e5df · Cited by 135
Li, Y., Deuring, J., Peppelenbosch, M. P., Kuipers, E. J., de Haar, C., & van der Woude, C. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs214 · Cited by 134 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundMicrosatellite instability in colorectal cancer
Nojadeh, J. N., Sharif, S. B., & Sakhinia, E. (2018) · PubMed · doi:10.17179/excli2017-948 · Cited by 131
On how mammalian transcription factors recognize methylated DNA
Buck-Koehntop, B. A., & Defossez, P.-A. (2013) · Epigenetics · doi:10.4161/epi.23632 · Cited by 125 · cited 1×
“The demethylation process is facilitated by ten–eleven translocation proteins (TET), the family of proteins that catalyzes the conversion of 5-mC to 5-hydroxycytosine, and subsequently, to cytosine [72].”
BackgroundAmatu, A., Sartore-Bianchi, A., Moutinho, C., Belotti, A., Bencardino, K., Chirico, G., Cassingena, A., Rusconi, F., Esposito, A., Nichelatti, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3518 · Cited by 122
Recent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
Ishikawa, T., Fujita, T., Suzuki, Y., Okabe, S., Yuasa, Y., Iwai, T., & Kawakami, Y. (2003) · PubMed · Cited by 117
Rio, M. D., Mollévi, C., Bibeau, F., Vié, N., Sèlves, J., Emile, J., Roger, P., Gongora, C., Robert, J., Tubiana-Mathieu, N., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.003 · Cited by 113
Patnaik, S., & Anupriya (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00588 · Cited by 109
Cheng, Y.-W., Pincas, H., Bacolod, M. D., Schemmann, G., Giardina, S. F., Huang, J., Barral, S., Idrees, K., Khan, S. A., Zeng, Z., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0216 · Cited by 108
Young, J. P., & Jass, J. R. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0164 · Cited by 104
Regulation of DNA methyltransferase 1 by interactions and modifications
Qin, W., Leonhardt, H., & Pichler, G. (2011) · Nucleus · doi:10.4161/nucl.2.5.17928 · Cited by 98 · cited 7×
“DNMT1 is also modified by SUMOylation, a process where small ubiquitin modifying proteins (SUMO) are attached by covalent bonds to DNMT1 [76].”
BackgroundInfluentialEnglish, D. R., Young, J. P., Simpson, J. A., Jenkins, M. A., Southey, M. C., Walsh, M. D., Buchanan, D. D., Barker, M., Haydon, A. M., Royce, S. G., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0091 · Cited by 97
Moarefi, A. H., & Chedin, F. L. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.050 · Cited by 96
Patel, S. A. A., Bhambra, U., Charalambous, M. P., David, R. M., Edwards, R. J., Lightfoot, T., Boobis, A. R., & Gooderham, N. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.540 · Cited by 96 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundSchwitalle, Y., Linnebacher, M., Ripberger, E., Gebert, J. F., & Doeberitz, M. V. K. (2004) · PubMed · Cited by 93
Tham, C., Chew, M., Soong, R., Lim, J.-F., Ang, M., Tang, C., Zhao, Y., Ong, S. Y. K., & Liu, Y. (2014) · Cancer · doi:10.1002/cncr.28802 · Cited by 90
Momparler, R. L., Momparler, L. F., & Samson, J. (1984) · Leukemia Research · doi:10.1016/0145-2126(84)90059-6 · Cited by 89
Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes
Kaneda, A., & Yagi, K. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01712.x · Cited by 87
Nagasaka, T., Sharp, G. B., Notohara, K., Kambara, T., Sasamoto, H., Isozaki, H., MacPhee, D. G., Jass, J. R., Tanaka, N., & Matsubara, N. (2003) · PubMed · Cited by 84
Bhangu, J. S., Beer, A., Mittlböck, M., Tamandl, D., Pulverer, W., Schönthaler, S., Taghizadeh, H., Stremitzer, S., Kaczirek, K., Gruenberger, T., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002901 · Cited by 83
Lee, H. S., Hwang, S. M., Kim, T. S., Kim, D., Park, D. J., Kang, S., Kim, H., & Park, K. U. (2013) · Translational Oncology · doi:10.1593/tlo.13118 · Cited by 83
Role of epigenetics in transformation of inflammation into colorectal cancer
Yang, Z.-H., Dang, Y.-Q., & Ji, G. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i23.2863 · Cited by 81 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundDNA Methyltransferase Activity Assays: Advances and Challenges
Poh, W. J., Wee, C. P. P., & Gao, Z. (2016) · Theranostics · doi:10.7150/thno.13438 · Cited by 81 · cited 1×
“DNMT3A and DNMT3B are essential for de novo methylation of the genome, to keep a cell’s specific methylation profile, and also for methylation of newly integrated retroviral sequences [67,68].”
BackgroundNagai, Y., Sunami, E., Yamamoto, Y., Hata, K., Okada, S., Murono, K., Yasuda, K., Otani, K., Nishikawa, T., Tanaka, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14439 · Cited by 79
SUMOylation enhances DNA methyltransferase 1 activity
Lee, B., & Muller, M. T. (2009) · Biochemical Journal · doi:10.1042/bj20090142 · Cited by 76 · cited 7×
“DNMT1 is also modified by SUMOylation, a process where small ubiquitin modifying proteins (SUMO) are attached by covalent bonds to DNMT1 [76].”
BackgroundInfluentialKawakami, K., Matsunoki, A., Kaneko, M., Saito, K., Watanabe, G., & Minamoto, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01776.x · Cited by 75
The emerging role of Polycomb repressors in the response to DNA damage
Vissers, J. H. A., van Lohuizen, M., & Citterio, E. (2012) · Journal of Cell Science · doi:10.1242/jcs.107375 · Cited by 75 · cited 1×
“The mechanism of alternative gene silencing by Polycomb complex is through the trimethylation of histone H3, chromatin compaction, and regulation of H2A by monoubiquitylation [58,59].”
BackgroundGarrido‐Laguna, I., McGregor, K., Wade, M. L., Weis, J. R., Gilcrease, W., Burr, L., Soldi, R., Jakubowski, L., Davidson, C., Morrell, G., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9947-6 · Cited by 71
The Polycomb group protein EZH2 directly controls DNA methylation
Marker, P. C. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.02.005 · Cited by 70
Pishvaian, M. J., Slack, R. S., Jiang, W., He, A. R., Hwang, J. J., Hankin, A., Dorsch‐Vogel, K., Kukadiya, D., Weiner, L. M., Marshall, J. L., et al. (2018) · Cancer · doi:10.1002/cncr.31309 · Cited by 69
Son, G. M., Kwon, M.-S., Shin, D., Shin, N., Ryu, D., & Kang, C. (2019) · Medicine · doi:10.1097/md.0000000000015164 · Cited by 69
Farkas, S. A., Vymetalkova, V., Vodickova, L., Vodicka, P., & Nilsson, T. K. (2014) · Epigenomics · doi:10.2217/epi.14.7 · Cited by 67
Self-citationDaher-Reyes, G. S., Merchán, B., & Yee, K. W. L. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1667331 · Cited by 67
Genetic alterations and epigenetic alterations of cancer-associated fibroblasts
Du, H., & Che, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.5451 · Cited by 66 · cited 1×
“They differ phenotypically and functionally from normal fibroblasts (NFs) and provide cancer cells with nutrition and energy and stimulate the proliferation, invasion, and metastasis of cells [94,95].”
BackgroundEpigenetics and Inflammatory Markers: A Systematic Review of the Current Evidence
González-Jaramillo, V., Portilla-Fernández, E., Glišić, M., Voortman, T., Ghanbari, M., Bramer, W. M., Chowdhury, R., Nijsten, T. E. C., Dehghan, A., Franco, O. H., et al. (2019) · International Journal of Inflammation · doi:10.1155/2019/6273680 · Cited by 66
Comparison of transformation efficiency of human active and inactive X-chromosomal DNA
Venolia, L., & Gartler, S. M. (1983) · Nature · doi:10.1038/302082a0 · Cited by 64
Keeping the Centromere under Control: A Promising Role for DNA Methylation
Scelfo, A., & Fachinetti, D. (2019) · Cells · doi:10.3390/cells8080912 · Cited by 64
Golbabapour, S., Majid, N. B. A., Hassandarvish, P., Hajrezaie, M., Abdulla, M. A., & Hadi, A. H. A. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2012.0105 · Cited by 64 · cited 1×
“Polycomb proteins repress gene expression by histone modification, especially during development and differentiation [56] and silence tumor suppressor genes [57].”
BackgroundLee, J., Kang, M. J., Han, H.-Y., Lee, M.-G., Jeong, S.-I., Ryu, B., Ha, T.-K., Her, N.-G., Han, J., Park, S. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1026 · Cited by 58 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundHochhauser, D., Glynne-Jones, R., Potter, V., Grávalos, C., Doyle, T. J., Pathiraja, K., Zhang, Q., Zhang, L., & Sausville, E. A. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0710 · Cited by 57
DNA methylation and chromatin modifiers in colorectal cancer
Vymetalkova, V., Vodicka, P., Vodenkova, S., Alonso, S., & Schneider-Stock, R. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.04.002 · Cited by 57 · cited 4×
“Demethylation drugs AZA and DAC are synthetic cytosine analogs, which have already been approved for the treatment of acute myeloid leukemia and myelodysplastic syndrome [5,219].”
BackgroundInfluentialSelf-citationMethylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
Han, S., Lee, H., Bae, J. M., Cho, N., Lee, K., Kim, T., Oh, D., Im, S., Bang, Y., Jeong, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27888 · Cited by 57
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
Pérez–Carbonell, L., Balaguer, F., Toiyama, Y., Egoavil, C. M., Rojas, E., Guarinós, C., Andreu, M. G., Llor, X., Castells, A., Jover, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104285 · Cited by 57
Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
Rubino, M., Kunderfranco, P., Basso, G., Greco, C. M., Pasqualini, F., Serio, S., Roncalli, M., Laghi, L., Mantovani, A., Papait, R., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1333215 · Cited by 56 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundGerecke, C., Scholtka, B., Löwenstein, Y., Fait, I., Gottschalk, U., Rogoll, D., Melcher, R., & Kleuser, B. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1972-8 · Cited by 56 · cited 1×
“In addition, hypermethylation of the ITGA4, TFPI2, and VIM gene promoters was noticed in inflammatory tissues of the colon, which may pose a higher risk to the development of colitis-associated CRC [36].”
BackgroundSelmin, O. I., Fang, C., Lyon, A. M., Doetschman, T. C., Thompson, P. A., Martinez, J. D., Smith, J. W., Lance, P., & Romagnolo, D. F. (2015) · Journal of Nutrition · doi:10.3945/jn.115.216580 · Cited by 56
Ab, G., Leyland-Jones, B., Hg, C., Davies, B., & Df, H. (1987) · PubMed · Cited by 56
Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studies
Aderka, D., Stintzing, S., & Heinemann, V. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30172-x · Cited by 54
Fennell, L., Dumenil, T., Wockner, L., Hartel, G., Nones, K., Bond, C., Borowsky, J., Liu, C., McKeone, D., Bowdler, L., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.002 · Cited by 54
Project set to map marks on genome
Abbott, A. (2010) · Nature · doi:10.1038/463596b · Cited by 54
Genome-wide profiling of DNA methylation in human cancer cells
Ogoshi, K., Hashimoto, S.-I., Nakatani, Y., Qu, W., Oshima, K., Tokunaga, K., Sugano, S., Hattori, M., Morishita, S., & Matsushima, K. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.003 · Cited by 53 · cited 1×
“These regions bear information that is very important for mediating the control gene expression [60,61].”
BackgroundSUN, W., Sun, Y., Zhu, M., Wang, Z., Zhang, H., Xin, Y., Jiang, G., Guo, X., Zhang, Z., & Liu, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2949 · Cited by 53
Kohonen‐Corish, M. R. J., Tseung, J., Chan, C., Currey, N., Dent, O. F., Clarke, S. J., Bokey, L., & Chapuis, P. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28619 · Cited by 53
Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
Castellano‐Castillo, D., Morcillo, S., Clemente‐Postigo, M., Crujeiras, A. B., Fernández‐García, J. C., Torres, E., Tinahones, F. J., & Macías‐González, M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0493-0 · Cited by 50 · cited 1×
“Many studies have presented that methylation of distinct genes (such as SOCS3 [27], PRKCDBP [28], CYP1B1 [29], PTX3 [30], FXR [31], and VDR [32]) is associated with inflammatory conditions, dysplasia, and malignant transformations, suggesting that these modifications are involved in inflammatory-induced carcinogenesis…”
BackgroundRoles of Methylated DNA Biomarkers in Patients with Colorectal Cancer
Ma, Z., Williams, M., Cheng, Y. Y., & Leung, W. K. (2019) · Disease Markers · doi:10.1155/2019/2673543 · Cited by 49
Decoding colorectal cancer epigenomics
Bairi, K. E., Tariq, K., Himri, I., Jaafari, A., Smaili, W., Kandhro, A. H., Gouri, A., & Ghazi, B. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.11.001 · Cited by 48
Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
Cha, Y., Kim, K.-J., Han, S., Rhee, Y.-Y., Bae, J. M., Wen, X., Cho, N., Lee, D., Lee, K.-H., Kim, T.-Y., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.176 · Cited by 47
A reciprocal role of prostate cancer on stromal DNA damage
Banerjee, J., Mishra, R., Li, X., Jackson, R. S., Sharma, A., & Bhowmick, N. A. (2013) · Oncogene · doi:10.1038/onc.2013.431 · Cited by 45
BERNAL, C., Vargas, M. F., Ossandon, F. J., Santibáñez, E., Urrutia, J., Víctor Luengo, J., Zavala, L. F., BACKHOUSE, C., PALMA, M., Argandoña, J., et al. (2008) · Biological Research · doi:10.4067/s0716-97602008000300007 · Cited by 45 · cited 1×
“However, many methylation alterations are cancer-specific and appear early in the cancer genome [85], long before the malignant transition, and enlarge with progression [86].”
BackgroundPrognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
Draht, M. X. G., Goudkade, D., Koch, A., Grabsch, H. I., Weijenberg, M. P., van Engeland, M., Melotte, V., & Smits, K. M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0461-8 · Cited by 44
Kwon, Y., Park, M., Jang, M., Yun, S., Kim, W. K., Kim, S., Paik, S., Lee, H. J., Hong, S., Kim, T. I., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17023 · Cited by 43
Choi, S.-W., & Friso, S. (2009) · CRC Press eBooks · doi:10.1201/9781420063561 · Cited by 39
Research works printed but not linked: 1
- Vaiserman, A.M. (2017). Epigenetics of Aging and Longevity, Academic Press. [1st ed.].
Cited by
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Fatma, H., Maurya, S. K., & Siddique, H. R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.008 · Cited by 177
Epigenetic Mechanisms of Aging and Aging-Associated Diseases
la Torre, A., Vecchio, F. L., & Greco, A. (2023) · Cells · doi:10.3390/cells12081163 · Cited by 150
“An example is represented by colorectal cancer (CRC) that often affects people over 50 years of age [85].”
BackgroundInfluentialGenetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 99
Filip, S., Vymetalkova, V. P., Petera, J., Vodičková, Ľ., Kubeček, O., John, S., Čečka, F., Krupova, M., Manethová, M., Červená, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155255 · Cited by 97
Self-citation
Metadata
- Authors
- Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V.
- Affiliations
- Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Videnska 1083, 14 200 Prague, Czech Republic
- Charles University (CZ)
- Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague, Czech Republic
- Corresponding author
- Vymetalkova, Veronika
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-06-24
- Volume
- 9
- Issue
- 6
- Pages
- 1540
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7349319
- OpenAlex
- W3038126636
- Cited by
- 57
- References
- 241
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 4
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grant Agency of the Ministry of Health of the Czech Republic (AZV 17-30920A and NV19-09-00237)
- Charles University Research Centre (UNCE/MED/006)
- Grant Agency of the Charles University (GAUK 302119)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer, DNA methylation, DNA methyltransferases, DNMT inhibitors, epigenetic therapy, DNA hypermethylation, chemoresistance, predictive biomarkers, molecular subtypes, epigenetic modifications
- MeSH terms
- Humans, Colorectal Neoplasms, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Consensus molecular subtypes (CMS) classification as proposed by Guinney et al. [131].](https://figures.cochat.ai/paper-figures/963c902904204d22894d0af4c77fd8c1/methylation-based-therapies-for-colorectal-cancer-figure-1.jpg)
